Leading drug makers’ outpatient sales drop in July

Korea's ten leading companies saw their outpatient sales decline in July from a year earlier, data showed Monday.

According to the data by Shinhan Investment Corp., outpatient sales by the ten companies stood at 204.5 billion won in July, down 0.7 percent from the same month of the previous year, while other Korean firms’ combined sales amounted to 315.2 billion won, showing a 4.7 percent in...